Received for publication 26 February 1980 ileum as well as in tissues exposed to cholera toxin. This finding suggests the possibility that aspirin may increase intestinal absorption even when diarrhoea is not caused by bacterial toxin. However, Nalin1' found that aspirin, given after the onset of intestinal secretion in dogs induced by cholera toxin, failed to prevent further secretion and for this reason considered a clinical trial of salicylates in cholera to be unjustified. Yet, indomethacin given after challenge with E. coli heat stable toxin (ST) effectively inhibits toxicity.8 These findings and claims indicate a need to investigate the potential antisecretory effects of such substances, particularly if they might have a useful, practical, therapeutic role in the control of fluid loss in childhood dairrhoeas.
Diarrhoea remains a major problem in malnourished children in developing countries. Bacterial overgrowth in the small intestine is common in such children1 and, although many of the organisms found in large numbers in their upper intestines are not generally considered to be enteric pathogens, they can inhibit intestinal transport of sugar2 and cause intestinal secretion of fluid3. It may be that diarrhoea in malnourished children is related to contamination of the upper intestine with such mixed bacterial populations as well as to recognised enteric pathogens such as V. cholerae, E. coli, Shigella sp., and Salmonella sp.
Aspirin has been shown to inhibit intestinal secretion caused by cholera toxin,4 while bismuth subsalicylate inhibits secretory effects of crude E. coli enterotoxin and cholera toxin.6 Other anti-inflammatory agents such as indomethacin have also been found to inhibit secretion caused by cholera toxin, Salmonella typhimurium, and Shigella flexneri7 as well as E. coli heat stable toxin (ST).8 Meanwhile, Farris et al.9 found that aspirin enhanced intestinal electrolyte transport in normal ileum as well as in tissues exposed to cholera toxin. This finding suggests the possibility that aspirin may increase intestinal absorption even when diarrhoea is not caused by bacterial toxin. However, Nalin1' found that aspirin, given after the onset of intestinal secretion in dogs induced by cholera toxin, failed to prevent further secretion and for this reason considered a clinical trial of salicylates in cholera to be unjustified. Yet, indomethacin given after challenge with E. coli heat stable toxin (ST) effectively inhibits toxicity.8 These findings and claims indicate a need to investigate the potential antisecretory effects of such substances, particularly if they might have a useful, practical, therapeutic role in the control of fluid loss in childhood dairrhoeas.
We have therefore investigated the effect of aspirin on intestinal transport of sugar and water in normal rat jejunum in vitro and in vivo with and without exposure to a range of bacteria isolated from the upper small intestinal secretions of malnourished Indonesian children with diarrhoea.
The organisms chosen were those we have previously found to affect intestinal transport processes ;2 3 E. coli known to produce heat labile (LT) or ST toxins or both were also included in the study. In particular, we have examined the effect of aspirin given after intestinal water secretion has been 683 induced by cell-free preparations of these microorganisms.
Methods

BACTERIAL STRAINS
Individual strains of Staphylococcus pyogenes, Staphylococcus epidermidis, Klebsiella pneumoniae, E. coli 055, Shigella sonnei, Salmonella typhimurium, and Candida tropicalis isolated from the upper intestinal aspirates of malnourished Indonesian children, and shown previously to interfere with intestinal transport of sugar, fluid, or electrolytes,2 3 were used in these studies. In addition porcine strains of E. coli 431 (serotype 0101: K30, 00 :NM) producing ST only and 263 serotype 08: K87, 88ab :H19) producing LT only, and the human strain H10407 (serotype 078: K80:H1O1) and B7A producing both LT and ST were tested.
PREPARATION OF CULTURE FILTRATES
Micro-organisms stored at -70°C were grown aerobically in 100 ml volumes of a casamino acidyeast extract medium" in 250 ml Erlenmeyer flasks in an environmental incubator shaker (New Brunswick Scientific, Edison, NJ, USA) at 300 rpm and 37°C for 24 hours. Cultures produced bacterial cell populations of approximately 108 per ml and were checked for microbiological purity and cell-free preparations made by centrifuging at 3000 rpm for 30 minutes followed by filtration through a Millipore type HA filter (Millipore Corp. Bedford, Mass., USA). This solution was dialysed overnight against phosphate-buffered saline. For for 10 to 50 minutes. After incubation, chambers were rinsed in buffer, the exposed tissue removed with a metal punch, then gently blotted and weighed.
Samples were then homogenised and deproteinised. '4 In the first series of experiments, acetyl salicylic acid was added to the incubation medium in a concentration of 1, 5, 10, 15, or 20 mM. The pH was adjusted to 7.4 with NaOH which added approximately 1.5 mmol (3 meq/l) of Na to the 10 mM solutions. Arbutin uptake was also measured in the presence of 20mM salicylic acid.
In a second group of studies jejunal segments were incubated with 3 mM arbutin in cell-free preparations of Klebsiella pneumoniae, Staphylococcus pyogenes, Candida albicans, or E. coli 263 prepared as described above. Results were compared with control values for arbutin uptake in uninoculated medium processed in the same ways with values for arbutin uptake with 10 mM salicylic acid added to the cell-free bacterial prepara.tions.
Jejunal arbutin uptake was also measured one hour after rats had been fed 20 mg/kg or 40 mg/kg aspirin or salicylic acid in 1 ml water by stomach tube. Arbutin was determined as free phenol'5 and 2-deoxy-glucose as described by Waravdekar and Saslaw. '6 Results are expressed as Vtmol arbutin per mg of tissue after correction for 2-deoxy-glucose space.
In vivo STUDIES OF INTESTINAL FLUID TRANSPORT
Perfusion fluid Cell-free bacterial preparations were used, as described above, with uninoculated medium in control experiments. Phenol red, 5 F±g per ml (British Drug Houses, London, UK), was added to the perfusate as a non-absorbable marker for measuring water transport. Recovery of phenol red was 99% (SE±1.58). 10 mM salicylic acid was added to the perfusion fluid in some experiments.
ABSORPTION EXPERIMENTS
Rats were anaesthetised by the intraperitoneal injection of urethane (ethyl carbamate), 1 g per kg body weight, and body temperature maintained by a thermostatically controlled heated pad. Two cannulae were introduced through incisions in the gut wall, one at each end of an intact segment of jejunum approximately 20 cm in length, and tied in position with black silk. The gut segment was washed with 3 ml of the perfusion solution described above, and then drained by gently syringing air through it. The segment was replaced in the abdominal cavity and perfused with the test solution at 10 ml per hour. After equilibration for 30 minutes, perfusate was collected in three 30 minute samples for 90 minutes. At the end of the perfusion, the test segment was drained and its length measured under the tension of a standard weight.
Uninoculated medium and cell-free preparations of Klebsiella pneumoniae, E. coli 055, 263, 431, H10407 and B7A, Shigella sonnei, Staphylococcus epidermidis, Staphylococcus pyogenes, and Candida tropicalis were perfused with and without the .addition of 10 mM acetyl salicylic acid.
To determine the effect of aspirin given after changes in fluid transport had appeared, animals were perfused with cell-free bacterial preparations as described above. After allowing 30 minutes equilibration, perfusate was collected for 30 minutes. Rats were then given 50 mg/kg acetyl salicylic acid subcutaneously and perfusate collected in two 30 minute samples for a further hour.
Phenol red was determined spectrophotometrically at 560 nm using 0.5 ml volumes of centrifuged samples made alkaline with 1 ml IN NaOH.
EXPRESSION OF RESULTS
Net water flux is expressed in ,iml of water transported per cm of intestine per hour; + indicates net absorption and -indicates net secretion. 'STATISTICAL METHODS Differences in arbutin uptake were assessed using multivariate analysis of variance in comparing curves for arbutin uptake as previously described.17 Net water flux was compared using analysis of variance. P<0.05 was considered to be significant.
Results
In vitro ARBUTIN UPTAKE
In absence of bacterial preparations Figure 1 shows that arbutin uptake increases with increasing concentrations of acetyl salicylic acid in the incubation medium. The difference was not statistically significant using 1 mM acetyl salicylic acid but there was a significant difference with 5, 10, 15, and 20 mM acetyl salicylic acid or 20 mM salicylic acid when compared with control values. (Fig. 2) . With 20 mg/kg of ASA the {arbutin} mean and SEM values at 10, 20, 30, 40, and 50 minutes were 3.5 (0.3), 4.1 (0.5), 4.4 (0.6), 4 8 (0.5), and 5.0 (0.5); with 40 mg/kg of ASA they were 4.1 (0.7), 5.3 (0.7), 5.6 (0.6), 60 (0.5), and 6.1 (0.5). In every instance n 8. Results were similar with feeding salicylic acid but the difference was significant only at the higher dose of 40 mg/kg.
In presence of bacterial preparations Arbutin uptake in the presence of cell-free preparations of E. coli, Staphylococcus pyogenes, Candida albicans, and Klebsiella pneumoniae was significantly less than control values. Addition of 10 mM salicylic acid to the incubation medium significantly increased arbutin uptake. Results are summarised in Table 1 , which shows the mean values and standard errors of the mean arbutin uptake after 30 minutes incubation.
Ill vivo FLUID TRANSPORT
Effect of adding salicylate to perfi/sion flitid Table 2 shows the effect on net water transport of adding 10 mM salicylic acid to the perfusion fluid. Net secretion of fluid into the intestinal lumen occurred during perfusion with cell-free bacterial preparations of all the E. coli strains tested, Shigella sonnei, Salmonella typhimlurium, Staphylococcus epidermidis, and Staplhylococcus pyogenes and net water absorption was decreased with Candida tropicalis. In experiments with added salicylate water absorption was increased in control animals and in those perfused with cell-free preparations of E. coli 055, 263, 431, H10407 and B7A, Klebsiella p/iei/moniae, Shigella sonnei, Staphylococcus epidermidis, Staphylococcus pyogenes, and Salmonella typhimurium. The addition of salicylate did not alter net water transport in the presence of cell-free preparations of Candida tropicalis and net water absorption was decreased with and without added salicylate. Table 3 .
Discussion
The findings of the present study add support to previous observations that salicylates can lessen the intestinal secretory effects induced by toxigenic micro-organisms. We found that intestinal uptake of arbutin, a non-metabolised analogue of D-glucose, was increased by the addition of acetyl salicylic or salicylic acid to the incubation medium in experiments with rat jejunum mounted in plexiglass chambers. Similar results were found when measuring jejunal arbutin uptake in rats one hour after they were fed acetyl salicylic acid. These findings agree with the reported effects of aspirin on intestinal transport measured by changes in electrical gradient across the intestinal mucosa.9 Jejunal arbutin uptake in vitro was decreased in the presence of cell-free preparations of E. coli, Staphylococcius pyogeties, Candida albicans, and Klebsiella pnieumoniiae. Arbutin uptake was then increased with each of these organisms after the addition of 10 mM salicylic acid to the incubation medium. This effect is similar to that of acetyl salicylic acid on electrical gradient across intestinal mucosa exposed to cholera toxin.9
In vivo, salicylates were found to increase net water absorption in rat jejunum exposed to cell-free preparations of several strains of E. coli, Klebsiella Subcutaneous injection of aspirin has been shown to be effective in decreasing fluid secretion induced by cholera toxin,4 although in that study the aspirin was given at the same time as ileal loops were exposed to cholera toxin. Farris et al.,'9 investigating the effect of aspirin added to the mucosal or serosal surfaces of rabbit ileal mucosa, found aspirin to be significantly more effective when added to the serosal side of the intestine. This led those authors to suggest that blood levels of aspirin, rather than luminal levels, may be important in preventing the effects of cholera toxin.
However, Nalin10 was unable to control cholera toxin-induced fluid secretion in dogs by adding aspirin to the contents of jejunal loops after changes in net water flux were established. Later, Ericsson et al.6 found that addition of bismuth subsalicylate to the contents of ileal loops in rabbits failed to prevent activity of E. coli or cholera toxin when given after water secretion had begun, although it was effective when given at the same time as the toxins.
We have found differences in the effectiveness of salicylates given at the same time as the toxin and when administered by injection after the net water flux had been affected. When given with bacterial preparations into the intestinal lumen, salicylates were effective with all organisms tested except Candida sp. Aspirin given by injection after fluid secretion had been induced by bacterial preparations appeared to be effective only with organisms producing fluid secretion only via activation of adenylate cyclase. The effect of E. coli ST, which does not act in this way, appears to persist after injection of aspirin. Failure to demonstrate an effect of aspirin given intraluminally after intestinal loops had been exposed to enterotoxins may be explained by inadequate blood levels of salicylate being attained.
Our results clearly show that salicylates are capable of antagonising toxin-induced intestinal fluid secretion even when given after exposure to the toxin. While this is not effective with all organisms tested, the range of bacteria affected suggests that the treatment may be useful clinically, particularly in malnourished children who are likely to have mixed bacterial overgrowth in the upper small intestine.'12223 These experimental data combined with the report that aspirin is useful in reducing diarrhoea in patients with radiationinduced enteritis,24 who may also have bacterial overgrowth in the small intestine,25 suggest that a clinical trial of salicylates in malnourished children with diarrhoea would be appropriate.
